<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29955150</article-id>
<article-id pub-id-type="pmc">6235877</article-id>
<article-id pub-id-type="publisher-id">124</article-id>
<article-id pub-id-type="doi">10.1038/s41386-018-0124-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuropsychopharmacology Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Inflaming sex differences in mood disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rainville</surname>
<given-names>Jennifer R.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1551-2178</contrib-id>
<name>
<surname>Hodes</surname>
<given-names>Georgia E.</given-names>
</name>
<address>
<phone>+540-232-8684</phone>
<email>ghodes@vt.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0694 4940</institution-id><institution-id institution-id-type="GRID">grid.438526.e</institution-id><institution>Department of Neuroscience, </institution><institution>Virginia Polytechnic Institute and State University, </institution></institution-wrap>1981 Kraft Drive, Blacksburg, VA 24060 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>19</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<volume>44</volume>
<issue>1</issue>
<fpage>184</fpage>
<lpage>199</lpage>
<history>
<date date-type="received">
<day>7</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© American College of Neuropsychopharmacology 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">Men and women often experience different symptoms or rates of occurrence for a variety of mood disorders. Many of the symptoms of mood disorders overlap with autoimmune disorders, which also have a higher prevalence in women. There is a growing interest in exploring the immune system to provide biomarkers for diagnosis of mood disorders, along with new targets for developing treatments. This review examines known sex differences in the immune system and their relationship to mood disorders. We focus on immune alterations associated with unipolar depression, bipolar depression, and anxiety disorders. We describe work from both basic and clinical research examining potential immune mechanisms thought to contribute to stress susceptibility and associated mood disorders. We propose that sex and age are important, intertwined factors that need to be included in future experimental designs if we are going to harness the power of the immune system to develop a new wave of treatments for mood disorders.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Neuroimmunology</kwd>
<kwd>Depression</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000874</institution-id>
<institution>Brain and Behavior Research Foundation (Brain &amp; Behavior Research Foundation)</institution>
</institution-wrap>
</funding-source>
<award-id>24805</award-id>
<principal-award-recipient>
<name>
<surname>Hodes</surname>
<given-names>Georgia E.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© American College of Neuropsychopharmacology 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>